Evidence map›Paper›PMID 39251918›Full record

ArticleBMC infectious diseases2024

Native valve endocarditis caused by Corynebacterium striatum without underlying structural heart disease or indwelling cardiovascular medical devices: a case report.

Daisuke Usuda, Yuhei Kojima, Rikuo Ono, Yuki Kaneoka, Masashi Kato, Yuto Sugawara, Runa Shimizu, Tomotari Inami, Eri Nakajima, Shiho Tsuge and 17 more

Abstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Daisuke UsudaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan. d.usuda.qa@juntendo.ac.jp.
Yuhei KojimaDepartment of Pharmacy, Juntendo University Nerima Hospital, 3-1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Rikuo OnoDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Yuki KaneokaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Masashi KatoDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Yuto SugawaraDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Runa ShimizuDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Tomotari InamiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Eri NakajimaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Shiho TsugeDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Riki SakuraiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Kenji KawaiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Shun MatsubaraDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Risa TanakaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Makoto SuzukiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Shintaro ShimozawaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Yuta HotchiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Ippei OsugiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Risa KatouDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Sakurako ItoDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Kentaro MishimaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Akihiko KondoDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Keiko MizunoDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Hiroki TakamiDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Takayuki KomatsuDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Tomohisa NomuraDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.
Manabu SugitaDepartment of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3- 1-10, Takanodai, Nerima-City, 177-8521, Tokyo, Japan.

Funding

JSPS KAKENHI JP24K15491
6 · The paper itself

Abstract

backgroundCorynebacterium striatum (C. striatum) is a gram-positive, anaerobic bacillus found both environmentally and in human skin and nasal mucosa flora. It is reportedly the etiologic agent of community-acquired and nosocomial diseases and is significantly associated with bacteremia and medical endovascular devices. This is the rare case of mitral valve native valve endocarditis (NVE) caused by C. striatum occurring in a young adult without underlying structural heart disease or indwelling cardiovascular medical devices successfully treated with multidisciplinary therapy. CASE PRESENTATION: The patient was a 28-year-old female with no medical history. She was transferred our hospital due to sudden onset of vertigo and vomit. A computed tomography on day 2 revealed the hydrocephalus due to the cerebellar infarction, and she underwent posterior fossa decompression for cerebellar infarction. An angiography on day 8 revealed a left vertebral artery dissection, which was suspected be the etiology. Afterwards, a sudden fever of 39 degrees developed on day 38. She was diagnosed with aspiration pneumonia and treated with ampicillin/sulbactam but was still febrile at the time of transfer for rehabilitation. Treatment continued with levofloxacin, the patient had no fever decline, and she was readmitted to our hospital. Readmission blood cultures (3/3 sets) revealed C. striatum, and an echocardiogram revealed an 11 mm long mitral valve vegetation, leading to NVE diagnosis. On the sixth illness day, cardiac failure symptoms manifested. Echocardiography revealed mitral valve rupture. She was transferred again on the 11th day of illness, during which time her mitral valve was replaced. C. striatum was detected in the vegetation. Following surgery, she returned to our hospital, and vancomycin administration continued. The patient was discharged after 31 total days of postoperative antimicrobial therapy. The patient experienced no exacerbations thereafter.

conclusionsWe report the rare case of C. striatum mitral valve NVE in a young adult without structural heart disease or indwelling cardiovascular devices. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Anti-Bacterial AgentsCorynebacteriumCorynebacterium InfectionsEndocarditis, BacterialAdultFemaleHumansMitral ValveAnti-Bacterial AgentsBacteremiaCase reportCorynebacterium striatumEtiologyNative valve endocarditisTreatment

Identifiers

PMID39251918
PMCPMC11384686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.